3PRI

Crystal Structure of Human B-Raf Kinase in Complex with a Non-Oxime Furopyridine Inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.50 Å
  • R-Value Free: 0.303 
  • R-Value Work: 0.241 
  • R-Value Observed: 0.245 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Non-oxime inhibitors of B-Raf(V600E) kinase.

Ren, L.Wenglowsky, S.Miknis, G.Rast, B.Buckmelter, A.J.Ely, R.J.Schlachter, S.Laird, E.R.Randolph, N.Callejo, M.Martinson, M.Galbraith, S.Brandhuber, B.J.Vigers, G.Morales, T.Voegtli, W.C.Lyssikatos, J.

(2011) Bioorg Med Chem Lett 21: 1243-1247

  • DOI: 10.1016/j.bmcl.2010.12.061
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • The development of inhibitors of B-Raf(V600E) serine-threonine kinase is described. Various head-groups were examined to optimize inhibitor activity and ADME properties. Several of the head-groups explored, including naphthol, phenol and hydroxyamidi ...

    The development of inhibitors of B-Raf(V600E) serine-threonine kinase is described. Various head-groups were examined to optimize inhibitor activity and ADME properties. Several of the head-groups explored, including naphthol, phenol and hydroxyamidine, possessed good activity but had poor pharmacokinetic exposure in mice. Exposure was improved by incorporating more metabolically stable groups such as indazole and tricyclic pyrazole, while indazole could also be optimized for good cellular activity.


    Organizational Affiliation

    Array BioPharma, 3200 Walnut Street, Boulder, CO 80301, USA.



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Serine/threonine-protein kinase B-raf
A, B
307Homo sapiensMutation(s): 0 
Gene Names: BRAFBRAF1RAFB1
EC: 2.7.11.1
Find proteins for P15056 (Homo sapiens)
Go to UniProtKB:  P15056
NIH Common Fund Data Resources
PHAROS  P15056
Protein Feature View
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
FP4
Query on FP4

Download CCD File 
A, B
3-(4-{[2-(pyrimidin-2-yl)furo[2,3-c]pyridin-3-yl]amino}-1H-indazol-3-yl)propan-1-ol
C21 H18 N6 O2
SYIQWALXOCKNEW-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.50 Å
  • R-Value Free: 0.303 
  • R-Value Work: 0.241 
  • R-Value Observed: 0.245 
  • Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 100.36α = 90
b = 100.36β = 90
c = 163.37γ = 90
Software Package:
Software NamePurpose
CrystalCleardata collection
CNSrefinement
CNXrefinement
MOSFLMdata reduction
SCALAdata scaling
CNSphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2011-02-02
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance